Literature DB >> 9861224

Prostate cancer: 6. Surgical treatment of localized disease.

S L Goldenberg1, E W Ramsey, M A Jewett.   

Abstract

A 65-year-old man undergoes a routine checkup before retiring. His wife has urged him to have his prostate examined, because she has read about testing for prostate cancer and a friend has just died of this disease. During the rectal examination, the man's physician discovers some firmness in the right lobe of the prostate gland. The patient has had no urinary symptoms and is in excellent general health. Sexual function is normal. There is no history of prostate cancer; his father died of a stroke at age 86 years. Testing shows that the patient's prostate-specific antigen level is 9.3 ng/mL, and he is referred to a urologist. Transrectal ultrasound-guided needle biopsy reveals adenocarcinoma with a Gleason score of 7 (intermediate grade). At a follow-up meeting with his physician, the patient says, "I have been doing some research, and it appears that I should have treatment. However, what is less clear to me is what form of therapy is best--surgery or radiation treatment. Please tell me what you can about the state of the art with respect to surgery."

Entities:  

Mesh:

Year:  1998        PMID: 9861224      PMCID: PMC1229822     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  22 in total

1.  Radical retropubic prostatectomy: limited benefit of autologous blood donation.

Authors:  J R Goad; J A Eastham; K B Fitzgerald; M W Kattan; M P Collini; D H Yawn; P T Scardino
Journal:  J Urol       Date:  1995-12       Impact factor: 7.450

2.  Morbidity and mortality following radical prostatectomy: a national analysis of Civilian Health and Medical Program of the Uniformed Services beneficiaries.

Authors:  S A Optenberg; B E Wojcik; I M Thompson
Journal:  J Urol       Date:  1995-06       Impact factor: 7.450

3.  Results of conservative management of clinically localized prostate cancer.

Authors:  G W Chodak; R A Thisted; G S Gerber; J E Johansson; J Adolfsson; G W Jones; G D Chisholm; B Moskovitz; P M Livne; J Warner
Journal:  N Engl J Med       Date:  1994-01-27       Impact factor: 91.245

4.  Mortality of patients after radical prostatectomy: analysis of recent Medicare claims.

Authors:  D H Mark
Journal:  J Urol       Date:  1994-09       Impact factor: 7.450

5.  Return of erections and urinary continence following nerve sparing radical retropubic prostatectomy.

Authors:  W J Catalona; J W Basler
Journal:  J Urol       Date:  1993-09       Impact factor: 7.450

6.  Patient-reported complications and follow-up treatment after radical prostatectomy. The National Medicare Experience: 1988-1990 (updated June 1993).

Authors:  F J Fowler; M J Barry; G Lu-Yao; A Roman; J Wasson; J E Wennberg
Journal:  Urology       Date:  1993-12       Impact factor: 2.649

7.  Sequelae of radical prostatectomy.

Authors:  M Jønler; E M Messing; P R Rhodes; R C Bruskewitz
Journal:  Br J Urol       Date:  1994-09

8.  Acute normovolemic hemodilution is a cost-effective alternative to preoperative autologous blood donation by patients undergoing radical retropubic prostatectomy.

Authors:  T G Monk; L T Goodnough; J D Birkmeyer; M E Brecher; W J Catalona
Journal:  Transfusion       Date:  1995-07       Impact factor: 3.157

9.  Nerve sparing radical prostatectomy: a different view.

Authors:  E S Geary; T E Dendinger; F S Freiha; T A Stamey
Journal:  J Urol       Date:  1995-07       Impact factor: 7.450

10.  Radical retropubic prostatectomy for localized carcinoma of the prostate in a large metropolitan hospital: changing trends over a 10-year period (1984-1994). Dallas Outcomes Research Group for Urological Disorders.

Authors:  S E Litwiller; B Djavan; B V Klopukh; J C Richier; C G Roehrborn
Journal:  Urology       Date:  1995-05       Impact factor: 2.649

View more
  8 in total

1.  Prostate cancer from a patient's perspective.

Authors:  D Grundy
Journal:  CMAJ       Date:  1999-06-29       Impact factor: 8.262

2.  Understanding obesity.

Authors:  J D Douketis
Journal:  CMAJ       Date:  1999-06-29       Impact factor: 8.262

3.  The more the better?

Authors:  M Simunovic; T To; B Langer
Journal:  CMAJ       Date:  1999-06-29       Impact factor: 8.262

4.  Understanding obesity.

Authors:  T M Stein
Journal:  CMAJ       Date:  1999-06-29       Impact factor: 8.262

5.  PSA screening: a view from the front lines. North York General-Branson Practice-Based Small Group.

Authors:  M Greiver; N Rosen
Journal:  CMAJ       Date:  2000-03-21       Impact factor: 8.262

Review 6.  Prostate cancer: 11. Alternative approaches and the future of treatment.

Authors:  J Trachtenberg; J Crook; I F Tannock
Journal:  CMAJ       Date:  1999-02-23       Impact factor: 8.262

7.  Prostate cancer: 8. Urinary incontinence and erectile dysfunction.

Authors:  M M Hassouna; J P Heaton
Journal:  CMAJ       Date:  1999-01-12       Impact factor: 8.262

8.  Quality of care indicators and their related outcomes: A population-based study in prostate cancer patients treated with radical prostatectomy.

Authors:  Colleen Webber; D Robert Siemens; Michael Brundage; Patti A Groome
Journal:  Can Urol Assoc J       Date:  2014-07       Impact factor: 1.862

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.